HonKuwa, with Academician Yoshiki Sawa, Ushering in a New Era of Innovative Drug R & D.

0
TOKYO, JAPAN – Media OutReach Newswire – 15 October 2024 – HonKuwa Pharmaceutical Co., Ltd. officially announces a strategic partnership with Professor Yoshiki Sawa, a world-renowned expert in the field of regenerative medicine and an academician of the Engineering Academy of Japan. Professor Sawa has been appointed as the honorary chief research scientist of HonKuwa. At the signing ceremony held at InterContinental Osaka, both parties jointly embark on a new chapter in the exploration of innovative drugs.

https://www.hndashengkeji.com/

The issuer is solely responsible for the content of this announcement.

About HonKuwa Pharmaceutical

Since its establishment, HonKuwa has been consistently dedicated to researching and producing health products with high quality standards, covering areas such as health foods, medical products, and medical devices. The company is committed to promoting the development of global health through continuous innovation and helping more people achieve a better quality of life.